In the Boardroom
Refine Search
Pharmaceutical
Women’s health specialist Columbia Laboratories has appointed Bridget Martell to the newly-created position of chief medical officer. 6 January 2015
Pharmaceutical
Synthetic cannabinoid specialist Zynerba Pharmaceuticals has appointed Richard Baron as vice president and chief financial officer. 5 January 2015
Pharmaceutical
Medical device company Echo Therapeutics has appointed Alan Schoenbart as chief financial officer. 2 January 2015
Pharmaceutical
Japan’s largest drugmaker Takeda Pharmaceutical has appointed Andy Plump as corporate officer and chief medical and scientific officer designate. 19 December 2014
Pharmaceutical
Respiratory disease specialist Verona Pharma has appointed Kenneth Newman to the newly-created chief medical officer position. 18 December 2014
Pharmaceutical
French drugmaker Ipsen has appointed François Garnier as executive vice president, general counsel of the company. 17 December 2014
Pharmaceutical
US-Israeli company Immune Pharmaceuticals has appointed Daniel Kazado chairman of the board, succeeding Daniel Teper. 15 December 2014
Pharmaceutical
Ophthalmic specialist Santen has appointed Paolo Casati as general manager of Santen Italy, following the company’s launch in the region. 11 December 2014
Pharmaceutical
Israel-based Teva Pharmaceuticals has appointed Yitzhak Peterburg as chairman of the board of directors. 27 November 2014
Pharmaceutical
PTC Therapeutics appoints Tuyen Ong senior vice president, head of clinical development and research
Pharma company PTC Therapeutics has appointed Tuyen Ong as senior vice president, head of clinical development and translational research. 27 November 2014
Pharmaceutical
Danish CNS specialist Lundbeck this morning announced the resignation of its chief executive, Ulf Wiinberg, with immediate effect. 24 November 2014
Pharmaceutical
The president of Japanese drug major Takeda Pharmaceutical’s (TYO: 4502) US subsidiary, Douglas Cole, has resigned, after 22 years with the company. 21 November 2014
Pharmaceutical
Belgian drug developer Ablynx has announced the appointment of Johan Heylen as chief commercial officer. 18 November 2014
Pharmaceutical
Ireland-headquartered generics major Actavis has appointed Maria Teresa (Tessa) Hilado as chief financial officer. 12 November 2014
Pharmaceutical
Global specialty pharma company Reckitt Benckiser has appointed Cary Claiborne as chief financial officer. 4 November 2014
Pharmaceutical
Rare disease specialist aTyr Pharma has appointed Fred Ramsdell as vice president of immunology. 3 November 2014
Pharmaceutical
Just a day after French pharma major Sanofi denied that the future of its chief executive was under discussion, at a board meeting convened at 8am this morning it decided unanimously to remove Christopher Viehbacher as chief executive of the company. 29 October 2014
Pharmaceutical
Chris Viehbacher, chief executive of French drug major Sanofi, has urged the company’s board to clarify rumors that he is to be dismissed, according to a letter published in French business newspaper Les Echos. 28 October 2014
Pharmaceutical
German pharma company Grünenthal Group has appointed Sascha Becker as group chief financial officer, commencing in the first quarter of 2015. 20 October 2014
Pharmaceutical
James Bowling, interim chief financial officer of Ireland-headquartered drugmaker Shire, has stepped down from the position. 20 October 2014
Pharmaceutical
UK-based NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announced the appointment of Michael Shih as chief executive (CEO) and to the board of directors, effective immediately. 16 December 2024
Pharmaceutical
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief medical officer (CMO) and will become a member of Gilead’s senior leadership team. Dr Berger succeeds Dr Merdad Parsey. 13 December 2024
Pharmaceutical
AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while under investigation in China. 4 December 2024
Pharmaceutical
Bausch Health Bausch Health (NYSE/TSX: BHC) has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. 3 December 2024
Pharmaceutical
Germany’s Evotec has said its chief operating officer Craig Johnstone will leave the business at the end of the year. 29 November 2024
Pharmaceutical
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that Dr Thomas Schinecker, chief executive (CEO) of Swiss pharma giant Roche (ROG: SIX), will take up the post as president of the trade association effective January 1, 2025. 26 November 2024
Pharmaceutical
Specialist pre-clinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has announced the appointment of Lee Patterson as its new chief executive. 25 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Pharmaceutical
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze